39 results
6-K
EX-99.1
CMMB
Chemomab Therapeutics Ltd
3 Jul 23
Current report (foreign)
3:49pm
(the “Annual Report”), a copy of which is available on our website at https://investors.chemomab.com/sec-filings.
CORPORATE GOVERNANCE
Overall Role … have complete access to management and the Board and its committees may retain their own respective advisors.
Corporate Governance Guidelines
Our
8-K
CMMB
Chemomab Therapeutics Ltd
5 Jun 23
Chemomab Therapeutics Announces Executive Leadership Changes and Provides a Corporate Update
7:00am
date. Dr. Darvish also serves as chairman of the compensation committee of the Board and is a member of the corporate governance and nominating
8-K/A
o8k4hp cyv5
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
8-K
z8vd 76nupnxaqrdrgmj
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
424B3
h15ni30200xsic
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
sejveq
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
u4d87cke5mqkxf t0
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-10.7
7j7p5jyov elcaq
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
980z6
20 Oct 20
Departure of Directors or Certain Officers
3:50pm